Adial Pharmaceuticals, Inc - Common Stock (ADIL)

The reverse split is intended to bring the company back into compliance with Nasdaq’s $1 minimum bid price rule.

Adial Pharmaceuticals received FDA backing for its Phase 3 AD04 trial, including endpoints and strategies for targeted populations in Alcohol Use Disorder treatment.

As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.

Let's have a look at what is happening on the US markets on Friday. Below you can find the stocks with an unusual volume in today's session.

Here are the top movers in Friday's session, showcasing the stocks with significant price changes.